"10.1371_journal.pone.0053910","plos one","2013-01-08T00:00:00Z","Hiroshi Furukawa; Shomi Oka; Kota Shimada; Shoji Sugii; Atsushi Hashimoto; Akiko Komiya; Naoshi Fukui; Tatsuo Nagai; Shunsei Hirohata; Keigo Setoguchi; Akira Okamoto; Noriyuki Chiba; Eiichi Suematsu; Taiichiro Miyashita; Kiyoshi Migita; Akiko Suda; Shouhei Nagaoka; Naoyuki Tsuchiya; Shigeto Tohma","Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan; Department of Rheumatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan; Department of Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan; Department of Rheumatology and Infectious Disease, Kitasato University School of Medicine, Sagamihara, Japan; Allergy and Immunological Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; Department of Rheumatology, Himeji Medical Center, National Hospital Organization, Himeji, Japan; Department of Rheumatology, Morioka Hospital, National Hospital Organization, Morioka, Japan; Department of Internal Medicine and Rheumatology, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan; Nagasaki Medical Center, National Hospital Organization, Omura, Japan; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan; Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan","Conceived and designed the experiments: HF NT ST. Performed the experiments: HF SO. Analyzed the data: HF. Contributed reagents/materials/analysis tools: HF K. Shimada SS AH AK NF TN SH K. Setoguchi AO NC ES TM KM AS SN ST. Wrote the paper: HF NT ST.","HF has the following conflicts. The following funders are supported in whole or in part by the indicated pharmaceutical companies. The Japan Research Foundation for Clinical Pharmacology is run by Daiichi Sankyo, the Takeda Science Foundation is supported by an endowment from Takeda Pharmaceutical Company and the Nakatomi Foundation was established by Hisamitsu Pharmaceutical Co., Inc. The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc. ST was supported by research grants from nine pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, and Teijin Pharma Limited. NT is supported by the Takeda Science Foundation, which is supported by an endowment from the Takeda Pharmaceutical Company. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. The other authors declare no financial or commercial conflicts of interest.","2013","01","Hiroshi Furukawa","HF",19,TRUE,3,2,1,3,TRUE,TRUE,TRUE,11,"4;5;7;8;9;11;12;13;14;16;17",TRUE
